Bar R S, Boes M
Biochem Biophys Res Commun. 1984 Oct 15;124(1):203-9. doi: 10.1016/0006-291x(84)90937-9.
Endothelial cells were cultured from bovine fat capillaries, aortae and pulmonary arteries and their interactions with 125I-IGF-I, 125I-MSA (an IGF-II), 125I-insulin and the corresponding unlabeled hormones were evaluated. Each endothelial culture showed similar binding parameters. With 125I-insulin, unlabeled insulin competed with high affinity while IGF-I and MSA were approximately 1% as potent. With 125I-MSA, MSA was greater than or equal to IGF-I in potency and insulin did not compete for binding. Using 125I-IGF-I, IGF-I was greater than or equal to MSA whereas insulin decreased 125I-IGF-I binding by up to 72%. Exposing cells to anti-insulin receptor antibodies inhibited 125I-insulin binding by greater than 90%, did not change 125I-MSA binding, while 125I-IGF-I binding was decreased by 30-44%, suggesting overlapping antigenic determinants between IGF-I and insulin receptors that were not present on MSA receptors. We conclude that cultured capillary and large vessel endothelial cells have distinct receptors for insulin, IGF-I and MSA (IGF-II).
从牛脂肪毛细血管、主动脉和肺动脉中培养内皮细胞,并评估它们与125I-胰岛素样生长因子-I(IGF-I)、125I-多价抑瘤蛋白(MSA,一种IGF-II)、125I-胰岛素以及相应未标记激素的相互作用。每种内皮细胞培养物都显示出相似的结合参数。对于125I-胰岛素,未标记的胰岛素以高亲和力竞争,而IGF-I和MSA的效力约为其1%。对于125I-MSA,MSA的效力大于或等于IGF-I,胰岛素不竞争结合。使用125I-IGF-I时,IGF-I的效力大于或等于MSA,而胰岛素使125I-IGF-I的结合减少高达72%。将细胞暴露于抗胰岛素受体抗体可使125I-胰岛素的结合抑制超过90%,不改变125I-MSA的结合,而125I-IGF-I的结合减少30%-44%,这表明IGF-I和胰岛素受体之间存在重叠的抗原决定簇,而MSA受体上不存在。我们得出结论,培养的毛细血管和大血管内皮细胞对胰岛素、IGF-I和MSA(IGF-II)具有不同的受体。